Page last updated: 2024-10-31

neostigmine and Convergent Strabismus

neostigmine has been researched along with Convergent Strabismus in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research Excerpts

ExcerptRelevanceReference
"A 70-year-old man with known vascular disease, who had bilateral internuclear ophthalmoplegia, and an 18-month-old girl with a long-term variable esotropia culminating in a postinfectious oculopharyngeal neuropathy both responded with a positive edrophonium chloride (Tensilon) test, strongly suggesting the diagnosis of myasthenia gravis."3.66Ocular myasthenia gravis mimicking pseudointernuclear ophthalmoplegia and variable esotropia. ( Acers, TE, 1979)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acers, TE1

Other Studies

1 other study available for neostigmine and Convergent Strabismus

ArticleYear
Ocular myasthenia gravis mimicking pseudointernuclear ophthalmoplegia and variable esotropia.
    American journal of ophthalmology, 1979, Volume: 88, Issue:3 Pt 1

    Topics: Aged; Diagnosis, Differential; Edrophonium; Esotropia; Female; Humans; Infant; Male; Myasthenia Grav

1979